Guangxi Wuzhou Zhongheng Group Co Ltd (600252) - Net Assets
Based on the latest financial reports, Guangxi Wuzhou Zhongheng Group Co Ltd (600252) has net assets worth CN¥7.26 Billion CNY (≈ $1.06 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥11.06 Billion ≈ $1.62 Billion USD) and total liabilities (CN¥3.80 Billion ≈ $556.30 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Guangxi Wuzhou Zhongheng Group Co Ltd (600252) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥7.26 Billion |
| % of Total Assets | 65.64% |
| Annual Growth Rate | 16.12% |
| 5-Year Change | -8.67% |
| 10-Year Change | 51.67% |
| Growth Volatility | 39.39 |
Guangxi Wuzhou Zhongheng Group Co Ltd - Net Assets Trend (1997–2024)
This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 600252 total assets for the complete picture of this company's asset base.
Annual Net Assets for Guangxi Wuzhou Zhongheng Group Co Ltd (1997–2024)
The table below shows the annual net assets of Guangxi Wuzhou Zhongheng Group Co Ltd from 1997 to 2024. For live valuation and market cap data, see 600252 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥7.51 Billion ≈ $1.10 Billion |
-9.21% |
| 2023-12-31 | CN¥8.28 Billion ≈ $1.21 Billion |
-0.15% |
| 2022-12-31 | CN¥8.29 Billion ≈ $1.21 Billion |
-4.61% |
| 2021-12-31 | CN¥8.69 Billion ≈ $1.27 Billion |
+5.62% |
| 2020-12-31 | CN¥8.23 Billion ≈ $1.20 Billion |
+28.61% |
| 2019-12-31 | CN¥6.40 Billion ≈ $936.15 Million |
+7.88% |
| 2018-12-31 | CN¥5.93 Billion ≈ $867.77 Million |
+5.96% |
| 2017-12-31 | CN¥5.60 Billion ≈ $818.98 Million |
+5.09% |
| 2016-12-31 | CN¥5.33 Billion ≈ $779.28 Million |
+7.48% |
| 2015-12-31 | CN¥4.95 Billion ≈ $725.03 Million |
-16.27% |
| 2014-12-31 | CN¥5.92 Billion ≈ $865.96 Million |
+60.41% |
| 2013-12-31 | CN¥3.69 Billion ≈ $539.83 Million |
+18.80% |
| 2012-12-31 | CN¥3.11 Billion ≈ $454.39 Million |
+55.23% |
| 2011-12-31 | CN¥2.00 Billion ≈ $292.73 Million |
+49.67% |
| 2010-12-31 | CN¥1.34 Billion ≈ $195.58 Million |
+131.67% |
| 2009-12-31 | CN¥576.93 Million ≈ $84.42 Million |
+27.65% |
| 2008-12-31 | CN¥451.95 Million ≈ $66.13 Million |
+8.96% |
| 2007-12-31 | CN¥414.81 Million ≈ $60.70 Million |
+16.21% |
| 2006-12-31 | CN¥356.94 Million ≈ $52.23 Million |
-7.31% |
| 2005-12-31 | CN¥385.08 Million ≈ $56.35 Million |
-19.15% |
| 2004-12-31 | CN¥476.29 Million ≈ $69.70 Million |
+8.52% |
| 2003-12-31 | CN¥438.88 Million ≈ $64.22 Million |
+2.47% |
| 2002-12-31 | CN¥428.29 Million ≈ $62.67 Million |
+7.26% |
| 2001-12-31 | CN¥399.28 Million ≈ $58.43 Million |
+6.32% |
| 2000-12-31 | CN¥375.55 Million ≈ $54.95 Million |
+152.44% |
| 1999-12-31 | CN¥148.77 Million ≈ $21.77 Million |
-6.31% |
| 1998-12-31 | CN¥158.79 Million ≈ $23.24 Million |
+19.50% |
| 1997-12-31 | CN¥132.88 Million ≈ $19.44 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Guangxi Wuzhou Zhongheng Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6070.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.92 Billion | 31.92% |
| Common Stock | CN¥3.35 Billion | 55.69% |
| Other Comprehensive Income | CN¥859.08 Million | 14.26% |
| Total Equity | CN¥6.02 Billion | 100.00% |
Guangxi Wuzhou Zhongheng Group Co Ltd Competitors by Market Cap
The table below lists competitors of Guangxi Wuzhou Zhongheng Group Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dezhan HealthCare Co Ltd
SHE:000813
|
$1.14 Billion |
|
Ingenia Communities Group
AU:INA
|
$1.14 Billion |
|
Three Squirrels
SHE:300783
|
$1.14 Billion |
|
Pharming Group NV
NASDAQ:PHAR
|
$1.14 Billion |
|
Waypoint REIT
AU:WPR
|
$1.14 Billion |
|
SILEX Systems Ltd
AU:SLX
|
$1.14 Billion |
|
Nanobiotix
NASDAQ:NBTX
|
$1.14 Billion |
|
Meren Energy
ST:MER
|
$1.14 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Guangxi Wuzhou Zhongheng Group Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,569,449,409 to 6,022,749,391, a change of -546,700,018 (-8.3%).
- Net loss of 376,979,139 reduced equity.
- Dividend payments of 90,891,996 reduced retained earnings.
- Share repurchases of 279,146,298 reduced equity.
- Other comprehensive income increased equity by 852,343,584.
- Other factors decreased equity by 652,026,169.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-376.98 Million | -6.26% |
| Dividends Paid | CN¥90.89 Million | -1.51% |
| Share Repurchases | CN¥279.15 Million | -4.63% |
| Other Comprehensive Income | CN¥852.34 Million | +14.15% |
| Other Changes | CN¥-652.03 Million | -10.83% |
| Total Change | CN¥- | -8.32% |
Book Value vs Market Value Analysis
This analysis compares Guangxi Wuzhou Zhongheng Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.37x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 30.71x to 1.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-12-31 | CN¥0.08 | CN¥2.45 | x |
| 1998-12-31 | CN¥0.10 | CN¥2.45 | x |
| 1999-12-31 | CN¥0.09 | CN¥2.45 | x |
| 2000-12-31 | CN¥0.23 | CN¥2.45 | x |
| 2001-12-31 | CN¥0.25 | CN¥2.45 | x |
| 2002-12-31 | CN¥0.26 | CN¥2.45 | x |
| 2003-12-31 | CN¥0.28 | CN¥2.45 | x |
| 2004-12-31 | CN¥0.28 | CN¥2.45 | x |
| 2005-12-31 | CN¥0.21 | CN¥2.45 | x |
| 2006-12-31 | CN¥0.23 | CN¥2.45 | x |
| 2007-12-31 | CN¥0.26 | CN¥2.45 | x |
| 2008-12-31 | CN¥0.34 | CN¥2.45 | x |
| 2009-12-31 | CN¥0.18 | CN¥2.45 | x |
| 2010-12-31 | CN¥0.44 | CN¥2.45 | x |
| 2011-12-31 | CN¥0.61 | CN¥2.45 | x |
| 2012-12-31 | CN¥0.95 | CN¥2.45 | x |
| 2013-12-31 | CN¥1.12 | CN¥2.45 | x |
| 2014-12-31 | CN¥1.71 | CN¥2.45 | x |
| 2015-12-31 | CN¥1.43 | CN¥2.45 | x |
| 2016-12-31 | CN¥1.52 | CN¥2.45 | x |
| 2017-12-31 | CN¥1.57 | CN¥2.45 | x |
| 2018-12-31 | CN¥1.74 | CN¥2.45 | x |
| 2019-12-31 | CN¥1.87 | CN¥2.45 | x |
| 2020-12-31 | CN¥2.00 | CN¥2.45 | x |
| 2021-12-31 | CN¥1.93 | CN¥2.45 | x |
| 2022-12-31 | CN¥1.90 | CN¥2.45 | x |
| 2023-12-31 | CN¥1.92 | CN¥2.45 | x |
| 2024-12-31 | CN¥1.79 | CN¥2.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Guangxi Wuzhou Zhongheng Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -16.60%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 1.82x
- Recent ROE (-6.26%) is below the historical average (10.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | 17.74% | 16.66% | 0.42x | 2.56x | CN¥9.70 Million |
| 1998 | 16.81% | 18.44% | 0.39x | 2.33x | CN¥10.26 Million |
| 1999 | 21.93% | 22.42% | 0.42x | 2.33x | CN¥16.87 Million |
| 2000 | 7.12% | 17.01% | 0.26x | 1.59x | CN¥-10.61 Million |
| 2001 | 7.44% | 15.31% | 0.28x | 1.76x | CN¥-10.00 Million |
| 2002 | 6.61% | 9.54% | 0.36x | 1.91x | CN¥-13.92 Million |
| 2003 | 6.11% | 7.89% | 0.31x | 2.50x | CN¥-17.03 Million |
| 2004 | 0.48% | 0.44% | 0.27x | 4.07x | CN¥-41.52 Million |
| 2005 | -28.71% | -29.62% | 0.20x | 4.82x | CN¥-129.41 Million |
| 2006 | 5.86% | 6.37% | 0.31x | 3.00x | CN¥-14.63 Million |
| 2007 | 8.94% | 12.80% | 0.25x | 2.77x | CN¥-4.35 Million |
| 2008 | 10.56% | 7.48% | 0.60x | 2.35x | CN¥2.48 Million |
| 2009 | 22.14% | 17.65% | 0.47x | 2.65x | CN¥68.94 Million |
| 2010 | 29.91% | 28.52% | 0.47x | 2.23x | CN¥265.32 Million |
| 2011 | 18.77% | 32.59% | 0.30x | 1.95x | CN¥175.21 Million |
| 2012 | 22.08% | 35.15% | 0.42x | 1.50x | CN¥374.11 Million |
| 2013 | 20.15% | 18.58% | 0.66x | 1.64x | CN¥374.01 Million |
| 2014 | 26.96% | 49.61% | 0.40x | 1.36x | CN¥1.00 Billion |
| 2015 | 10.51% | 38.73% | 0.22x | 1.24x | CN¥25.07 Million |
| 2016 | 9.20% | 29.30% | 0.26x | 1.22x | CN¥-42.81 Million |
| 2017 | 10.82% | 29.54% | 0.30x | 1.23x | CN¥45.62 Million |
| 2018 | 10.35% | 18.59% | 0.46x | 1.22x | CN¥20.72 Million |
| 2019 | 11.65% | 19.53% | 0.49x | 1.23x | CN¥105.60 Million |
| 2020 | 8.22% | 15.31% | 0.31x | 1.75x | CN¥-122.13 Million |
| 2021 | 4.63% | 9.71% | 0.27x | 1.80x | CN¥-355.41 Million |
| 2022 | 1.21% | 2.91% | 0.23x | 1.80x | CN¥-572.75 Million |
| 2023 | 1.28% | 2.72% | 0.27x | 1.78x | CN¥-572.64 Million |
| 2024 | -6.26% | -16.60% | 0.21x | 1.82x | CN¥-979.25 Million |
Industry Comparison
This section compares Guangxi Wuzhou Zhongheng Group Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $4,691,234,838
- Average return on equity (ROE) among peers: 6.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Guangxi Wuzhou Zhongheng Group Co Ltd (600252) | CN¥7.26 Billion | 17.74% | 0.52x | $1.14 Billion |
| Shenzhen Neptunus Bioengineering Co Ltd (000078) | $903.62 Million | 4.28% | 2.45x | $1.16 Billion |
| Anhui Fengyuan Pharmaceutical Co Ltd (000153) | $1.22 Billion | 5.35% | 1.27x | $441.99 Million |
| Shan Dong Dong-E E-Jiao Co Ltd (000423) | $9.87 Billion | 20.71% | 0.25x | $5.01 Billion |
| Livzon Pharmaceutical Group Inc (000513) | $1.07 Billion | 3.83% | 0.46x | $2.80 Billion |
| Wedge Industrial Co Ltd (000534) | $1.15 Billion | 11.42% | 1.59x | $3.04 Billion |
| Yunnan Baiyao Group Co Ltd (000538) | $9.03 Billion | 25.71% | 0.43x | $13.75 Billion |
| Hainan Haiyao Co Ltd (000566) | $275.57 Million | 17.28% | 1.12x | $947.33 Million |
| Tus Pharmaceutical Group Co Ltd (000590) | $231.22 Million | -38.13% | 1.23x | $389.67 Million |
| Northeast Pharmaceutical Group Co Ltd (000597) | $4.29 Billion | 2.31% | 2.07x | $1.03 Billion |
| Jilin Aodong Pharmaceutical Group Co Ltd (000623) | $18.87 Billion | 8.83% | 0.08x | $3.32 Billion |
About Guangxi Wuzhou Zhongheng Group Co Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicines; and xueshuantong for shooting, zhonghua dieda pills, angong niuhuang pills, shedan chuanbei liquid, fuyanjing capsules, jieshitong tablets, yanjianning tablets, sodium fluorescein injection under the Zhon… Read more